• Profile
Close

Using the risk assessment index (RAI) to predict 90-day mortality and hospital utilization in cancer patients at UPMC hillman cancer center

Journal of Clinical Oncology Oct 25, 2018

Garcia CA, et al. - Authors gauged frailty assessment via the Risk Assessment Index (RAI) in cancer patients and its ability to predict hospital utilization and 90-day mortality. Findings suggested the probability of RAI to be utilized for predicting 90-day mortality in cancer patients. Unplanned hospitalizations were more common in the patients at greatest risk of 90-day mortality. The difference in RAI scores was statistically significant between patients with and without unplanned ED visits/hospitalizations, but this difference was too small to be clinically meaningful.

Methods

  • RAI was completed by new patients with solid tumor malignancies at the UPMC Hillman Cancer Center from September 15, 2017 to January 31, 2018.
  • They abstracted the age, cancer type and stage, and treatments.
  • The Wolff Center at UPMC provided ED visits, hospitalizations and mortality data.
  • They performed Mann-Whitney U and likelihood-ratio tests comparing RAI, ED usage/hospitalizations, and mortality.
  • They excluded the elective hospital admissions.

Results

  • As per data, 273 patients completed the RAI.
  • Findings suggested 58.6% of pts to be male and average age to be 62.7 (21-88), and the average RAI score to be 39.9 (IQR 35-44).
  • Melanoma (22.7%), prostate (14.3%), and lung (11.4%) were the most common cancer types.
  • Stage IV cancer was seen in 43.6% of patients.
  • Within 90 days after RAI, at least one unplanned ED visit or hospitalization were experienced by 51 patients (18.7%), and 10 patients (3.7%) were deceased.
  • Compared to an average RAI of 39.4 (IQR 35-43) for patients without an ED visit/hospitalization, patients with an ED visit/hospitalization had an average RAI of 42 (IQR 37-46): a 2.6-point difference (p=0.008); 90-day mortalities had an average RAI score of 47.5 (IQR 42-53) compared to 39.6 (IQR 35-44) for non-mortalities: a 7.9-point difference (p=0.003).
  • Mortality was experienced by 6 of 242 (2.5%) patients without a hospitalization whereas 4 of 31 (12.9%) patients with a hospitalization experienced mortality (p=0.017).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay